1Sakharova O V,Taal M W,Brenner B M. Pathogenesis of diabetic nephropathy: focus on transforming growth factorβ and connective tissue growth factor [J]. Cur Opin Nephrol Hypertens,2001,10(6) :727-738.
2Hanson N Q,Aras O,Yang F,et al. C677T and A1298C polymorphisms of the methylnetetrahydr of late reductase gene:incidence and effect of combined genotypes on plasma fasting and postmethi onine load homocysteine in vascular disease [J]. Clin Chem, 2001, 47(4):661-666.
3Hoogeveen E K,Kostense P J,Jager A et al. Serum homocysteine level and protein in intake are related to risk of microalbuminuria [J]. Kidney Int, 1998,54(1):203-209.
4Chico A, Perez A, Cordoba A, et al, Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease [J]? Diabetologia, 1998, 41 (6) :684-693.
5Leehey D J,Singh A K,Alavi N,et al. Role of angiotensin Ⅱ in diabetic nephropathy [J]. Kidney Int Suppl, 2000,77: S93-98.
7Zhou G, Li C, Cai L. Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor-beta independent pathway [J]. Am J Pathol, 2004, 165 (6) :2033-2043.
8Liu B C,Sun J, Chen Q, et al. Role of connective tissue growth factor in mediating hypertrophy of human proximal tubular cells induced by angiotensin Ⅱ [J]. Am J Nephrol,2003, 23(6) :429-437.
9RuperezM,Ruiz-OrtegaM,Esteban V, et al. Angiotensin Ⅱ increases connective tissue growth factor in the kidney [J]. AmJ Pathol,2003,163(5):1937- 1947.
3Mayer EL,Jacobsen DW,Robinson K.Homocysteine and coronary atherosclerosis.J Am Coll Cardiol,1996;27(3):517～21
4Nygard O,Nordrehaug JE,Refsum H et al.Plasma homocysteine levels and mortality in patients with coronary artery disease.N Engl J Med,1997;337(4):230～6
5Starkebaum G,Harlan JM.Endothelial cell injury due to copper catalyzed hydrogen peroxide generation from homocysteine.J Clin Invest,1986;77(4):1370～6
6Lentz SR,Sobey CG,Piegors DJ et al.Vascular dysfunction in monkeys with diet-induced hyperhomocysteinemia.J Clin Inves,1996;98(1):24～9
7Dugas AJ.Evaluation of the totral peroxyl radical scavenging capacity of flavonoids:Structure activity relationships.J Nat Prod,2000;63(3):327～31
8Kuklmann M.Inhibition of oxidant induced lipid peroxidation in renal tubular epithelial cells (LIC-PK1) by quercetin.Free Radic Res,1998;29(5):451～60
9Zielinska M.Antioxidative activity of flavonoids in stimulated human neutrophils.Folia Histochem Cytobiol,2000;38(1):25～31
4Li Y,Zhou L,Liu F,et al. Mast cell infiltration is involved in renal interstitial fibrosis in a rat model of protein-overload nephropathy. Kidney Blood Press Res, 2010,33 (3) : 240-248.
5Galli SJ. New concepts about the mast cell. N Engl J Med, 1993,328(4) :257-265.
6El-Koraie AF,Baddour NM,Adam AG,et al. Role of stem cell factor and mast cells in the progression of chronic glomeru- lonephritides. Kidney Int, 2001,60(1) : 167-172.
7Puxeddu I, Piliponsky AM, Bachelet I, et al. Mast cells in allergy and beyond. Int J Biochem Cell Biol, 2003, 35 (12): 1601-1607.
8Araki Y,Andoh A,Nakamura F,et al. Mast cells may not play a crucial role in the pathogenesis of experimental closed duode- nal loop-induced panereatitis in rats. Pancreas, 2002, 24 (3) ; 298-302.
9Klahr S,Morrissey J. Obstructive nephropathy and renal fibro- sis. Am J Physiol Renal Physiol, 2002,283 (5) : F861-875.
10Wang W, Koka V,Lan HY. Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton), 2005,10(1):48-56.
